Contrary to popular belief, curing a disease can be more economically valuable than relying on ongoing monthly treatments. Recent findings show that a one-time cure, achieving the same patient outcomes without recurring prescriptions, can offer over twice the financial return. Chief Futurist Brett Winton covers more on The Brainstorm.
|
Snap’s $2,195 AR glasses are coming, Mic...
Amid heightened anticipation, Kevin Wars...
Believers in Elon Musk's astronomic visi...
Looking for the newest cloud provider re...
Snap is launching Specs, the company’s f...
Think you missed the boat on this AI win...
Evan Spiegel, Snap CEO, joins 'Power Lun...
CNBC’s Megan Cassella reports on the lat...
Anthropic and the US government are once...
Kevin Warsh will chair his first Federal...
Looking for the newest competitive strat...
Bloomberg’s Ed Ludlow tracks SpaceX's va...
To understand Donald Trump's America, it...
Sara Araghi, portfolio manager at Frankl...
Looking for the newest milestone shaping...